AbbVie Inc (ABBV)
167.80
-1.74
(-1.03%)
USD |
NYSE |
Apr 24, 16:00
167.00
-0.80
(-0.48%)
After-Hours: 20:00
AbbVie Gross Profit (TTM): 33.90B for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 33.90B |
September 30, 2023 | 36.26B |
June 30, 2023 | 38.60B |
March 31, 2023 | 39.39B |
December 31, 2022 | 40.64B |
September 30, 2022 | 40.26B |
June 30, 2022 | 40.42B |
March 31, 2022 | 39.44B |
December 31, 2021 | 38.75B |
September 30, 2021 | 37.36B |
June 30, 2021 | 35.26B |
March 31, 2021 | 32.54B |
December 31, 2020 | 30.42B |
September 30, 2020 | 27.94B |
June 30, 2020 | 26.65B |
March 31, 2020 | 26.37B |
December 31, 2019 | 25.83B |
September 30, 2019 | 25.41B |
June 30, 2019 | 25.25B |
March 31, 2019 | 25.16B |
December 31, 2018 | 25.04B |
September 30, 2018 | 24.21B |
June 30, 2018 | 23.19B |
March 31, 2018 | 22.26B |
December 31, 2017 | 21.17B |
Date | Value |
---|---|
September 30, 2017 | 20.96B |
June 30, 2017 | 20.51B |
March 31, 2017 | 20.14B |
December 31, 2016 | 19.81B |
September 30, 2016 | 19.49B |
June 30, 2016 | 19.34B |
March 31, 2016 | 18.85B |
December 31, 2015 | 18.36B |
September 30, 2015 | 17.77B |
June 30, 2015 | 16.92B |
March 31, 2015 | 16.17B |
December 31, 2014 | 15.53B |
September 30, 2014 | 15.03B |
June 30, 2014 | 14.67B |
March 31, 2014 | 14.50B |
December 31, 2013 | 14.21B |
September 30, 2013 | 14.32B |
June 30, 2013 | 14.25B |
March 31, 2013 | 14.03B |
December 31, 2012 | 13.87B |
September 30, 2012 | 13.62B |
June 30, 2012 | 13.39B |
March 31, 2012 | 13.13B |
December 31, 2011 | 12.80B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
25.25B
Minimum
Jun 2019
40.64B
Maximum
Dec 2022
33.72B
Average
35.26B
Median
Jun 2021
Gross Profit (TTM) Benchmarks
Amgen Inc | 19.74B |
Immunogen Inc (DELISTED) | 283.75M |
Johnson & Johnson | 61.53B |
Eli Lilly and Co | 27.04B |
Merck & Co Inc | 43.99B |